| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 04/24/2008 | CA2666878A1 Enantiomer-enriched alpha-,omega amino alcohol derivatives, their production and use as insect- and mite-repelling agents |
| 04/24/2008 | CA2666406A1 Substituted sulfonamide derivatives for use as bradykinin 1 receptor modulators |
| 04/23/2008 | EP1913000A2 Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis |
| 04/23/2008 | EP1912945A1 N-(pyridin-4-yl)-2-phenylbutanamides as androgen receptor modulators |
| 04/23/2008 | EP1912944A1 New salt iii |
| 04/23/2008 | EP1912943A1 New salt i |
| 04/23/2008 | EP1912942A1 Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases. |
| 04/23/2008 | EP1912941A1 Novel piperidine derivatives |
| 04/23/2008 | EP1912679A2 Amine-containing lipids and uses thereof |
| 04/23/2008 | EP1635828B1 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 04/23/2008 | EP1007033B1 Lymphocyte function antigen-1 antagonists |
| 04/23/2008 | CN101165053A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 04/23/2008 | CN101165052A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion |
| 04/23/2008 | CN100383126C Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 04/23/2008 | CN100383122C Process of extracting lycopdine A from plant |
| 04/23/2008 | CN100383121C Substituted benzyl ester and its preparation process and novel process for preparing substituted mopipe therefrom |
| 04/23/2008 | CN100383120C Method for preparing chiral disubstituted or alpha, alpha'-double instituted N-acylpyrrolidine or N-acylpiperidine |
| 04/22/2008 | US7361767 First reactive functional group used to provide attachment to a surface of a substrate, second reactive functional group is a N-sulfonyldicarboximide group reacted with an amine-containing material, to form a connector group between the substrate and amine containing material (protein, peptide, dna rna) |
| 04/22/2008 | US7361755 Transition-metal-catalyzed process for the conversion of alkenes to sterically hindered substituted n-alkoxyamines |
| 04/22/2008 | US7361671 E.g.,(6-Ethyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrr (2,3-b)pyridin-1-yl)acetic acid; interacts with and inhibits aldose reductase; antidiabetic agents and diabetic complications; gout; hypoglycemic and antiarthritic |
| 04/22/2008 | US7361670 Amide derivatives as NMDA receptor antagonists |
| 04/22/2008 | US7361666 Ligands for cellular receptors, including opiate receptors; side effect reduction; base structure is a saturated nitrogen-containing ring substituted with a tertiary amide that is N-substituted with an arylalkyl group |
| 04/22/2008 | US7361658 2-acylaminothiazole derivative or salt thereof |
| 04/22/2008 | US7361648 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 04/22/2008 | US7361647 hydroquinone derivatives of the Geldanamycin family; heat shock protein (chaperone) Hsp90 antagonist; improved solubility and air stability; antiproliferative and anticarcinogenic agents |
| 04/22/2008 | CA2302669C Piperidinylmethyloxazolidinone derivative |
| 04/17/2008 | WO2008045671A1 Matrix metalloprotease inhibitors |
| 04/17/2008 | WO2008045564A2 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 04/17/2008 | WO2008045015A1 Imino and amino sugar purification |
| 04/17/2008 | WO2008044632A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | WO2008011539A3 Anesthetic compounds |
| 04/17/2008 | WO2007143745A3 Substituted phenyl acetic acids as dp-2 antagonists |
| 04/17/2008 | WO2007056340A3 Disinfectant and antiseptic pyridinium and thiazolium compounds and methods of using the same |
| 04/17/2008 | US20080090873 Sulfonamide derivatives |
| 04/17/2008 | US20080090869 Antidiabetic agents, carbohydrate and lipid metabolic disorders; 2-(amino-substituted piperidin-1-yl)benzimidazoles; N-[2-(3-Aminopiperidin-1-yl)-1-(3-methylbut-2-enyl)-1H-benzimidazol-6-y]-benzamide trifluoroacetic acid salt for example; use in combination with other drugs |
| 04/17/2008 | US20080090868 Antidiabetic agents; 2-(amino-substituted piperidin-1-yl)benzimidazoles; N-(4-Chlorobenzyl)-2-(3-aminopiperidin-1-yl)-1-(4-fluorobenzyl)-1H-benzimidazole-6-carboxamide hydrochloride for example; use in combination with other antidiabetic, antilipemic agents |
| 04/17/2008 | US20080090867 Azole derivatives in the form of lipase and phospholipase inhibitors |
| 04/17/2008 | US20080090866 Cosmetic Use of Piperidine Derivatives |
| 04/17/2008 | US20080090854 Cxcr2 inhibitors |
| 04/17/2008 | US20080090839 Phenoxymethylalkyne inhibitors of lta4h for treating inflammation |
| 04/17/2008 | US20080090828 insecticides for soil-borne insects, such as termites and white grubs; less costly and safer to use on crops; N-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methylene}piperidyl)methyl]phenyl}ethoxycarboxamide, N-oxide |
| 04/17/2008 | US20080090798 Heterocyclic Substituted Aminoazacycles Useful as Central Nervous System Agents |
| 04/17/2008 | US20080090796 Useful in the treatment of neurological and psychiatric disorders associated with glutamatergic neurotransmission dysfunction and diseases; schizophrenia; 2,4-dichloro-N-{[4-(cyclopropylmethyl)-1-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-yl]methyl}benzamide |
| 04/17/2008 | US20080090782 Inhibit DNA-dependent protein kinase; reduced side effects caused by radiation and chemotherapy drugs |
| 04/17/2008 | CA2666084A1 1-naphthyl alkylpiperidine derivative |
| 04/16/2008 | EP1911745A1 Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanone)-2-ylidene]methylpiperidine |
| 04/16/2008 | EP1911743A1 Cyclic amine compound |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/16/2008 | EP1910317A1 1-amino linked compounds |
| 04/16/2008 | EP1910292A1 Piperidine derivative as tachykinin receptor antagonist |
| 04/16/2008 | EP1910291A1 Process for the preparation of donepezil and intermediate compounds thereof as well as hydrates of donepezil |
| 04/16/2008 | EP1910290A2 Gpcr agonists |
| 04/16/2008 | EP1909791A1 G-protein coupled receptor agonists |
| 04/16/2008 | CN101163677A Crystalline forms of a biphenyl compound |
| 04/16/2008 | CN101163676A Dopamine transporter inhibitors for use in treatment of movement disorders and other cns indications |
| 04/16/2008 | CN101163673A New muscarinic receptor antagonists |
| 04/16/2008 | CN101163669A Acetylene derivatives |
| 04/16/2008 | CN101161645A Urea derivatives as well as preparation method and uses thereof |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381423C Novel piperidine derivatives as modulators of chemokine receptor CCR5 |
| 04/15/2008 | US7358365 Process for the controlled increase in the molecular weight of polyethylenes |
| 04/15/2008 | US7358359 Antibacterial agents |
| 04/15/2008 | US7358251 Bcl-XL inhibitors; N-{[4-({(1R)-5-(dimethylamino)-1-[(phenylthio)methyl]pentyl}amino)-3-nitrophenyl]sulfonyl}-4-(4-fluorophenyl)piperidine-1-carboxamide; useful for promoting apoptosis; Anticancer agents; autoimmune diseases; antiinflammatory agents |
| 04/10/2008 | WO2008042926A1 Cyclic modulators of chemokine receptor activity |
| 04/10/2008 | WO2008042688A2 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| 04/10/2008 | WO2008041095A1 Sulfonamide derivatives as adrenergic agonists and muscarinic antagonists |
| 04/10/2008 | WO2008040934A1 Hdac inhibitors |
| 04/10/2008 | WO2008040367A1 Lercanidipine hydrobromide, a process for its preparation, crystalline forms and compositions thereof |
| 04/10/2008 | WO2008040043A1 Process for the preparation of pleuromutilins |
| 04/10/2008 | WO2007144652A3 Parp inhibitors |
| 04/10/2008 | WO2007144394A3 Pharmaceutical use of substituted piperidine carboxamides |
| 04/10/2008 | US20080086008 N-{2-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]ethyl}-2-trifluoromethylbenzamide; starting with a halogenobenzoyl derivative to produce a N-acetoxymethylcarboxamide derivative and then coupling it with a 2-pyridyl acetate derivative; pesticide |
| 04/10/2008 | US20080086007 O-[2-(pyrazole-1-yl)pyridine-5-yl]methyl acetophenone oxime; reacting pyrazole in dimethylformamide, with O-(2-chloropyridine-5-yl)methyl acetonphenone oxime in presence of a base sodium hydride |
| 04/10/2008 | US20080086006 Process for Making Substituted Piperidines |
| 04/10/2008 | US20080085973 Nitroxide Compounds for Minimizing Scorch in Crosslinkable Compositions |
| 04/10/2008 | US20080085899 Tetrahydrothiopyrano pyrazole cannabinoid modulators |
| 04/10/2008 | US20080085894 Alpha-(n-sulfonamido)acetamide derivatives as beta-amyloid inhibitors |
| 04/10/2008 | US20080085893 N-Hydroxy (2S)-2-hydroxy phenyl or heteroaryl sulfonamide derivatives; for example, N-Hydroxy (2S)-2-hydroxy-3-{N-[4-(4- chlorophenoxy)phenyl], N- methanesulfonylamino}propionamide; for treating disorders related to matrix metalloproteases, particularly useful for treating strokes; |
| 04/10/2008 | US20080083626 Ionic compound |
| 04/10/2008 | CA2665428A1 Hdac inhibitors |
| 04/10/2008 | CA2665385A1 Sulfonamide derivatives as adrenergic agonists and muscarinic antagonists |
| 04/10/2008 | CA2665347A1 Process for the preparation of pleuromutilins |
| 04/10/2008 | CA2664688A1 Phlorizin analogs as inhibitors of sodium glucose co-transporter 2 |
| 04/09/2008 | EP1908762A2 Organic compounds |
| 04/09/2008 | EP1908761A1 Organic compounds |
| 04/09/2008 | EP1908750A1 Process for the preparation of pleuromutilins |
| 04/09/2008 | EP1908471A1 Tetrahydropyridines as renin inhibitors |
| 04/09/2008 | EP1907372A1 Substituted cyclohexyl derivatives as nk-3 receptor antagonists |
| 04/09/2008 | EP1907359A2 3,5-substituted piperidine derivatives effective on renin-related disorders |
| 04/09/2008 | EP1594867B1 Phenylacetamides and their use as glucokinase modulators |
| 04/09/2008 | EP0958287B2 Sulfamide-metalloprotease inhibitors |
| 04/09/2008 | CN100379724C Inhibition of pulp and paper yellowing using nitroxides and other coadditives |
| 04/09/2008 | CN100379423C Topical medicine composite containing cholinergic drug or calcium channel paralyser |
| 04/08/2008 | US7355048 Process for preparing 1-(6-methylpyridin-3-yl)-2-[4- (methylsulphonyl)phenyl]ethanone |
| 04/08/2008 | US7355046 Chronic obstructive pulmonary dusease; asthma |
| 04/08/2008 | US7355042 Sleep disorders; side effect reduction |
| 04/08/2008 | US7354938 4[2(2,4chlorophenyl)pyrazol]-phenyl-cyclopropan; 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor; antidiabrtic agent, obesity, insulin resistance; improved physicochemical (stability) and biological (activity to inhibit HSD1, specificity, bioavailability, metabolism) |
| 04/08/2008 | US7354895 Phosphinyloxy, oxime and carboxylic acid derivatives which are useful as carboxypeptidase U inhibitors |
| 04/08/2008 | CA2188924C Arylpiperidine and arylpiperazine derivatives and drugs containing the same |
| 04/03/2008 | WO2008038637A1 Method for production of free amine |